Skip to content

Cesarean Trial of Staples vs. Sutures

Cesarean Randomized Control Trial Of Sutures vs. Staples (CROSS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01211600
Acronym
CROSS
Enrollment
746
Registered
2010-09-29
Start date
2010-06-30
Completion date
2014-12-31
Last updated
2019-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section, Wound Complications, Patient Satisfaction, Pain Measurement

Keywords

Staples, Sutures, Wound infections, Cosmesis, Aesthetic appearance of skin incision

Brief summary

To determine whether the rate of wound complications differs based on method of closure of skin incision (staples vs. suture) after cesarean delivery.

Detailed description

Despite this large number of cesareans performed annually, there is a paucity of data to suggest which technique is superior for closure of the skin incision with regards to wound complications, including wound separation and infection. As the morbidity associated with a cesarean delivery is usually related to wound complications, especially infection, we feel that it is important to examine this outcome by comparing the current skin closure techniques: staples versus suture.

Interventions

OTHERStaples

Interrupted Ethicon Staples

OTHERSuture

Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)

Sponsors

Main Line Health
CollaboratorOTHER
Thomas Jefferson University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Women undergoing cesarean delivery for pregnancy greater than 23 weeks gestation.

Exclusion criteria

* Poorly controlled diabetes (defined as ≥ 50% of fasting or 2 hour postprandial glucose levels \> 95 and 120 respectively within the week prior to delivery), * Vertical skin incisions * Chronic steroid use * Active lupus flare * HIV/AIDS * Current treatment for cancer or a history of radiation to the abdomen/pelvis * Current treatment with immunosuppressant medications secondary to history of transplantation * Emergency cesarean(precluding informed consent prior to surgery) * Lack of access to a phone * Allergy to suture or staple material

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Wound ComplicationsWithin 6 weeks of postpartumThe primary outcome is to evaluate the rate of wound complications for patients undergoing cesarean whose skin incision is closed with staples versus with suture. Wound complications included infection, hematoma, seroma, and separation and readmission for wound complication.

Secondary

MeasureTime frameDescription
Patient Satisfaction With Closure Method and Scar AppearanceImmediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.Whether the patient's satisfaction with the incision differed based on closure method (staples vs sutures) using 10-point Likert scale on which 1 is completely dissatisfied and 10 is completely satisfied.
Pain PerceptionImmediately postpartum to time of discharge, which is typically 3-4 days post-cesareanWhether the patient's perception of pain associated with the incision differed based on closure method (staples vs sutures). Patients were asked to rate pain on a scale from 0 (no pain) to 10 (extreme pain) using a visual graph of facial expressions.
Additional Provider VisitsWithin 6 weeks postpartumMean number of visits per participant (All wound visits, number of visits for women who were diagnosed with wound complications, number of visits for women who were not diagnosed with a wound complication).
Number of Participants With Primary Versus Repeat CesareanAt randomization.Randomization stratum - BMI (over/under 30) and Cesarean (primary or repeat)
Intraoperative Trial Details - Duration of Operation and Skin ClosureTime of CesareanDuration of operation: skin incision to skin closure Duration of skin closure: fascial closure to skin closure
Patient Scar Assessment Scale Scores for Evaluation of CosmesisImmediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.Patient evaluation of cosmesis of the cesarean incision based on closure method: staples vs sutures. Surgical scars were evaluated using Patient Scar Assessment Scale (PSAS). The PSAS evaluates six items: pain, itchiness, color, stiffness, thickness, and irregularity. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 6-60. Lower scores indicate closer resemblance to normal skin and are superior.
Length of Hospital StayImmediate postpartum.Length of hospital stay (days)
Number of Participants That Received Anticoagulation Within 24 HoursWithin 24 hours postpartum.Number of participants that received anticoagulation within 24 hours of procedure (preoperatively or postoperatively)
Number of Participants Diagnosed With EndomyometritisImmediate postpartum.Number of participants diagnosed with endomyometritis requiring antibiotics
Change in Hemoglobin Pre-operatively to Post-operativelyUp to 72 hours before and 24 hours after cesarean.Median change in hemoglobin from preoperative value (g/dL) to post-operatively.
Observer Evaluation of Cosmesis of the Cesarean Incision Based on Closure Method: Staples vs Sutures.Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.Surgical scars were evaluated using Observer Scar Assessment Scale (OSAS). The OSAS evaluates five items: vascularity, pigmentation, thickness, relief, and pliability. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 5-50. Lower scores indicate closer resemblance to normal skin and are superior.
Intraoperative Trial Details - Closure of Subcutaneous TissueTime of CesareanNumber of participants requiring subcutaneous tissue closure

Countries

United States

Participant flow

Participants by arm

ArmCount
Suture
Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)
370
Staples
Interrupted Ethicon Staples
376
Total746

Baseline characteristics

CharacteristicStaplesTotalSuture
Age, Continuous31.0 years31.0 years31.0 years
Number of Previous Cesareans
0 Previous Cesareans
177 Participants357 Participants180 Participants
Number of Previous Cesareans
1 Previous Cesarean
132 Participants252 Participants120 Participants
Number of Previous Cesareans
More than 1 Previous Cesarean
67 Participants137 Participants70 Participants
Pregnancy History - Singleton Gestation351 Participants704 Participants353 Participants
Race/Ethnicity, Customized
African American
167 Participants325 Participants158 Participants
Race/Ethnicity, Customized
Asian
22 Participants38 Participants16 Participants
Race/Ethnicity, Customized
Caucasian
154 Participants316 Participants162 Participants
Race/Ethnicity, Customized
Hispanic
24 Participants43 Participants19 Participants
Race/Ethnicity, Customized
Other
8 Participants23 Participants15 Participants
Race/Ethnicity, Customized
Unknown
1 Participants1 Participants0 Participants
Sex: Female, Male
Female
376 Participants746 Participants370 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Term Gestation329 Participants646 Participants317 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 3700 / 376
other
Total, other adverse events
18 / 37040 / 376
serious
Total, serious adverse events
0 / 3700 / 376

Outcome results

Primary

Number of Participants With Wound Complications

The primary outcome is to evaluate the rate of wound complications for patients undergoing cesarean whose skin incision is closed with staples versus with suture. Wound complications included infection, hematoma, seroma, and separation and readmission for wound complication.

Time frame: Within 6 weeks of postpartum

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
SutureNumber of Participants With Wound ComplicationsTotal patients with at least 1 wound complicatin18 Participants
SutureNumber of Participants With Wound ComplicationsInfection9 Participants
SutureNumber of Participants With Wound ComplicationsHematoma2 Participants
SutureNumber of Participants With Wound ComplicationsSeroma5 Participants
SutureNumber of Participants With Wound ComplicationsSeparation6 Participants
SutureNumber of Participants With Wound ComplicationsReadmission for wound complication2 Participants
StaplesNumber of Participants With Wound ComplicationsSeparation28 Participants
StaplesNumber of Participants With Wound ComplicationsTotal patients with at least 1 wound complicatin40 Participants
StaplesNumber of Participants With Wound ComplicationsSeroma6 Participants
StaplesNumber of Participants With Wound ComplicationsInfection14 Participants
StaplesNumber of Participants With Wound ComplicationsReadmission for wound complication3 Participants
StaplesNumber of Participants With Wound ComplicationsHematoma4 Participants
Secondary

Additional Provider Visits

Mean number of visits per participant (All wound visits, number of visits for women who were diagnosed with wound complications, number of visits for women who were not diagnosed with a wound complication).

Time frame: Within 6 weeks postpartum

Population: The number analyzed in the Number of visits - diagnosed wound complication and Number of visits - no diagnosed wound complication rows indicates the breakdown of subjects within each arm that did and did not have a diagnosed wound complication.

ArmMeasureGroupValue (MEAN)
SutureAdditional Provider VisitsAll wound visits.9 Number of Visits per participant
SutureAdditional Provider VisitsNumber of visits - diagnosed wound complication2.7 Number of Visits per participant
SutureAdditional Provider VisitsNumber of visits - no diagnosed wound complication.8 Number of Visits per participant
StaplesAdditional Provider VisitsAll wound visits1.5 Number of Visits per participant
StaplesAdditional Provider VisitsNumber of visits - diagnosed wound complication2.9 Number of Visits per participant
StaplesAdditional Provider VisitsNumber of visits - no diagnosed wound complication1.4 Number of Visits per participant
Secondary

Change in Hemoglobin Pre-operatively to Post-operatively

Median change in hemoglobin from preoperative value (g/dL) to post-operatively.

Time frame: Up to 72 hours before and 24 hours after cesarean.

ArmMeasureValue (MEDIAN)
SutureChange in Hemoglobin Pre-operatively to Post-operatively-1.8 g/dL
StaplesChange in Hemoglobin Pre-operatively to Post-operatively-1.8 g/dL
Secondary

Intraoperative Trial Details - Closure of Subcutaneous Tissue

Number of participants requiring subcutaneous tissue closure

Time frame: Time of Cesarean

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
SutureIntraoperative Trial Details - Closure of Subcutaneous Tissue201 Participants
StaplesIntraoperative Trial Details - Closure of Subcutaneous Tissue202 Participants
Secondary

Intraoperative Trial Details - Duration of Operation and Skin Closure

Duration of operation: skin incision to skin closure Duration of skin closure: fascial closure to skin closure

Time frame: Time of Cesarean

ArmMeasureGroupValue (MEDIAN)
SutureIntraoperative Trial Details - Duration of Operation and Skin ClosureDuration of Operation58.5 Minutes
SutureIntraoperative Trial Details - Duration of Operation and Skin ClosureDuration of Skin Closure15 Minutes
StaplesIntraoperative Trial Details - Duration of Operation and Skin ClosureDuration of Operation51 Minutes
StaplesIntraoperative Trial Details - Duration of Operation and Skin ClosureDuration of Skin Closure6 Minutes
Secondary

Length of Hospital Stay

Length of hospital stay (days)

Time frame: Immediate postpartum.

ArmMeasureValue (MEDIAN)
SutureLength of Hospital Stay4.4 Days
StaplesLength of Hospital Stay4.5 Days
Secondary

Number of Participants Diagnosed With Endomyometritis

Number of participants diagnosed with endomyometritis requiring antibiotics

Time frame: Immediate postpartum.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
SutureNumber of Participants Diagnosed With Endomyometritis11 Participants
StaplesNumber of Participants Diagnosed With Endomyometritis7 Participants
Secondary

Number of Participants That Received Anticoagulation Within 24 Hours

Number of participants that received anticoagulation within 24 hours of procedure (preoperatively or postoperatively)

Time frame: Within 24 hours postpartum.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
SutureNumber of Participants That Received Anticoagulation Within 24 Hours14 Participants
StaplesNumber of Participants That Received Anticoagulation Within 24 Hours17 Participants
Secondary

Number of Participants With Primary Versus Repeat Cesarean

Randomization stratum - BMI (over/under 30) and Cesarean (primary or repeat)

Time frame: At randomization.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
SutureNumber of Participants With Primary Versus Repeat CesareanBMI 30 or greater - primary cesarean delivery109 Participants
SutureNumber of Participants With Primary Versus Repeat CesareanBMI 30 or greater - repeat cesarean delivery126 Participants
SutureNumber of Participants With Primary Versus Repeat CesareanBMI less than 30 - primary cesarean delivery71 Participants
SutureNumber of Participants With Primary Versus Repeat CesareanBMI less than 30 - repeat cesarean delivery64 Participants
StaplesNumber of Participants With Primary Versus Repeat CesareanBMI less than 30 - repeat cesarean delivery67 Participants
StaplesNumber of Participants With Primary Versus Repeat CesareanBMI 30 or greater - primary cesarean delivery106 Participants
StaplesNumber of Participants With Primary Versus Repeat CesareanBMI less than 30 - primary cesarean delivery71 Participants
StaplesNumber of Participants With Primary Versus Repeat CesareanBMI 30 or greater - repeat cesarean delivery132 Participants
Secondary

Observer Evaluation of Cosmesis of the Cesarean Incision Based on Closure Method: Staples vs Sutures.

Surgical scars were evaluated using Observer Scar Assessment Scale (OSAS). The OSAS evaluates five items: vascularity, pigmentation, thickness, relief, and pliability. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 5-50. Lower scores indicate closer resemblance to normal skin and are superior.

Time frame: Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.

ArmMeasureValue (MEDIAN)
SutureObserver Evaluation of Cosmesis of the Cesarean Incision Based on Closure Method: Staples vs Sutures.12 score on a scale
StaplesObserver Evaluation of Cosmesis of the Cesarean Incision Based on Closure Method: Staples vs Sutures.13 score on a scale
Secondary

Pain Perception

Whether the patient's perception of pain associated with the incision differed based on closure method (staples vs sutures). Patients were asked to rate pain on a scale from 0 (no pain) to 10 (extreme pain) using a visual graph of facial expressions.

Time frame: Immediately postpartum to time of discharge, which is typically 3-4 days post-cesarean

ArmMeasureGroupValue (MEDIAN)
SuturePain Perception48 - 72 hours4.3 score on a scale
SuturePain Perception24 - 47 hours4.3 score on a scale
SuturePain PerceptionPain at time of Discharge3.5 score on a scale
SuturePain PerceptionLess than 24 hours3.5 score on a scale
StaplesPain PerceptionPain at time of Discharge3.6 score on a scale
StaplesPain Perception48 - 72 hours4.2 score on a scale
StaplesPain PerceptionLess than 24 hours3.6 score on a scale
StaplesPain Perception24 - 47 hours4.3 score on a scale
Secondary

Patient Satisfaction With Closure Method and Scar Appearance

Whether the patient's satisfaction with the incision differed based on closure method (staples vs sutures) using 10-point Likert scale on which 1 is completely dissatisfied and 10 is completely satisfied.

Time frame: Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.

Population: Patient satisfaction data were available for 606 participants. Two participants in the Staples arm did not provide scores for scar appearance satisfaction. This is why we are representing 305 of the 307 subjects' responses to satisfaction of scar appearance.

ArmMeasureGroupValue (MEDIAN)
SuturePatient Satisfaction With Closure Method and Scar AppearanceSatisfaction with Closure Method9 score on a scale
SuturePatient Satisfaction With Closure Method and Scar AppearanceSatisfaction with Scar Appearance9 score on a scale
StaplesPatient Satisfaction With Closure Method and Scar AppearanceSatisfaction with Closure Method10 score on a scale
StaplesPatient Satisfaction With Closure Method and Scar AppearanceSatisfaction with Scar Appearance9 score on a scale
Secondary

Patient Scar Assessment Scale Scores for Evaluation of Cosmesis

Patient evaluation of cosmesis of the cesarean incision based on closure method: staples vs sutures. Surgical scars were evaluated using Patient Scar Assessment Scale (PSAS). The PSAS evaluates six items: pain, itchiness, color, stiffness, thickness, and irregularity. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 6-60. Lower scores indicate closer resemblance to normal skin and are superior.

Time frame: Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.

ArmMeasureValue (MEDIAN)
SuturePatient Scar Assessment Scale Scores for Evaluation of Cosmesis15 score on a scale
StaplesPatient Scar Assessment Scale Scores for Evaluation of Cosmesis20 score on a scale

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026